LORD, ABBETT & CO. LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 230 filers reported holding SAGE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.96 and the average weighting 0.5%.

Quarter-by-quarter ownership
LORD, ABBETT & CO. LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$38,913
+387.3%
827,577
+334.8%
0.13%
+362.1%
Q1 2023$7,986
-100.0%
190,333
-14.3%
0.03%
-72.6%
Q3 2019$31,144,000
-64.5%
221,994
-53.6%
0.11%
-62.8%
Q2 2019$87,629,000
-11.2%
478,611
-22.9%
0.28%
-13.4%
Q1 2019$98,717,000
+706.6%
620,668
+385.8%
0.33%
+631.1%
Q4 2018$12,238,000
-71.2%
127,758
-57.5%
0.04%
-61.9%
Q3 2018$42,455,000
-49.9%
300,565
-44.4%
0.12%
-52.2%
Q2 2018$84,664,000
+12.4%
540,878
+15.6%
0.25%
+10.3%
Q1 2018$75,357,000
-31.9%
467,854
-30.3%
0.22%
-28.9%
Q4 2017$110,609,000
+544.0%
671,535
+143.6%
0.32%
+530.0%
Q3 2017$17,174,000
-40.4%
275,665
-23.8%
0.05%
-41.9%
Q2 2017$28,805,000
-41.6%
361,688
-47.9%
0.09%
-41.9%
Q1 2017$49,359,000
+68.7%
694,506
+21.2%
0.15%
+66.3%
Q4 2016$29,260,000
-6.4%
573,054
-15.6%
0.09%
-6.3%
Q3 2016$31,270,000
+43.6%
679,048
-6.1%
0.10%
+39.7%
Q2 2016$21,778,000
+27.8%
722,800
+36.0%
0.07%
+25.9%
Q1 2016$17,037,000
-73.3%
531,404
-51.5%
0.05%
-71.9%
Q4 2015$63,855,000
+479.5%
1,095,283
+320.7%
0.19%
+481.8%
Q3 2015$11,019,000
-86.1%
260,368
-76.0%
0.03%
-84.2%
Q2 2015$79,359,000
+778.3%
1,087,109
+504.3%
0.21%
+808.7%
Q1 2015$9,036,000
+128.1%
179,897
+66.2%
0.02%
+130.0%
Q4 2014$3,961,000108,2260.01%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2017
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,966,688$120,204,00010.81%
Integral Health Asset Management, LLC 230,000$14,058,0004.30%
Asymmetry Capital Management, L.P. 102,462$6,262,0004.02%
ACUTA CAPITAL PARTNERS, LLC 225,000$13,752,0003.74%
DAFNA Capital Management LLC 158,306$9,676,0003.14%
Bain Capital Life Sciences Investors, LLC 499,100$30,505,0002.84%
Boxer Capital, LLC 1,094,000$66,865,0002.31%
Palo Alto Investors LP 590,200$36,073,0001.98%
Logos Global Management LP 250,000$15,280,0001.96%
Bellevue Group AG 1,579,504$96,539,0001.33%
View complete list of SAGE THERAPEUTICS INC shareholders